NEW YORK — Using a GLP-1 receptor agonist may lead to a wide range of psychiatric effects, and psychological support is an important part of patient management, according to a speaker.
August 10, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
SAN DIEGO — GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand…
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Stephen J. Kim, MD, discusses GLP-1 drugs and their…
Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other eye…
WASHINGTON — GLP-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists are not likely to…
PARK CITY, Utah — When used for weight loss, previously published literature has shown GLP-1s may lead to bone resorption and…
GLP-1 receptor agonists are best known for treating type 2 diabetes and obesity, yet a growing body of evidence suggests their…
